Notable Efficacy of Co-Treatment with FHD-286, a Dual BRG1/BRM ATP-Ase Inhibitor, and Menin or BET Inhibitor, Decitabine or Venetoclax Against AML with MLL-r or Mutant NPM1Warren C. Fiskus,Jessica Piel, Murphy Hentemann, Christopher Peter Mill,Christine Birdwell,Kaberi Das,John Davis,Hanxi Hou, Noor Alhamadani,Kevin Philip,Alicia Matthews,Tapan M. Kadia,Naval Daver,Sanam Loghavi,Branko Cuglievan,Courtney D. DiNardo,Kapil N. BhallaBlood(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要